Ampvolts Limited has launched its second and final call money issue size 1,60,00,000, available for subscription from 8 November 2024 to 22 November 2024. They own as of the record date, 11 October 2024. Each share has a face value of Rs. 2, and the right issue price is Rs. 30 per share (₹20 already paid).
Stay tuned with us for comprehensive details on the Ampvolts Ltd 2024 Rights Issue, including the issue size, entitlement, payment terms, and more.
Corporate Action | Details |
---|---|
Security Name | Ampvolts Limited |
Issue Open/Close | 08 Nov 2024 to 22 Nov 2024 |
Record Date | October 11, 2024 |
Second Call Money Issue Size (Shares) | 1,60,00,000 |
Second & Final Call Money | ₹10 |
Face Value | ₹2 per share |
Right Issue Price | ₹30 per share (₹20 Already Paid) |
Renunciation of Rights Entitlements | November 18, 2024 |
Terms of Payment | Final Call Notice Rs 10 for 1,60,00,000 partly paid-up Equity Shares Call Money of Rs 16,00,00,000/- (10*16000000) per Partly Paid-up Equity Share of Ampvolts Limited. |
Disclaimer: The Information compiled by CEBPL on a best efforts basis from information CEBPL received from third party vendors, believed to be reliable. The information may contain errors or omissions; and is subject to change without prior or additional notice. CEBPL provides corporate action information that may be of interest or relevance to CEBPL clients. This does not constitute a recommendation or advice by CEBPL, and CEBPL Clients may not rely upon it. CEBPL does not warrant that the information provided is accurate, timely, or complete. CEBPL Clients are urged to verify the information prior to using it in their investing and trading decisions, including, but not limited to, referral to independent financial news resources, company announcements, and regulatory filings or disclosures. "Investment in securities market are subject to market risks, read all the related documents carefully before investing". Registration granted by SEBI and certification from NISM in no way guarantee the performance of the intermediary or provide any assurance of retums to investors. Name of Compliance Officer-Prashant Salian Email Id-Prashant.salian@choiceindia.com Contact no. 022-67079999-Ext-2310. Name of Grievance Officer-Deepika Singhvi-Email Id-ig@choiceindia.com, Contact no. 022-67079999-Ext-834. choiceindia.com
Invest in best pharma mutual funds in India for 2020 with Investica. Explore our top recommended pharma mutual funds to start investing today.